Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics
Open Access
Abstract
Precision medicine relies on individually tailored therapeutic intervention taking into account individual variability. It is strongly dependent on the availability of target-specific drugs and/or imaging agents that recognize molecular targets and patient-specific disease mechanisms. The most sensitive molecular imaging modalities, Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET), rely on the interaction between an imaging radioprobe and a target. Moreover, the use of target-specific molecular tools for both diagnostics and therapy, theranostic agents, represent an established methodology in nuclear medicine that is assuming an increasingly important role in precision medicine. The design of innovative imaging and/or theranostic agents is key for further accomplishments in the field. G-protein-coupled receptors (GPCRs), apart from being highly relevant drug targets, have also been largely exploited as molecular targets for non-invasive imaging and/or systemic radiotherapy of various diseases. Herein, we will discuss recent efforts towards the development of innovative imaging and/or theranostic agents targeting selected emergent GPCRs, namely the Frizzled receptor (FZD), Ghrelin receptor (GHSR-1a), G protein-coupled estrogen receptor (GPER), and Sphingosine-1-phosphate receptor (S1PR). The pharmacological and clinical relevance will be highlighted, giving particular attention to the studies on the synthesis and characterization of targeted molecular imaging agents, biological evaluation, and potential clinical applications in oncology and non-oncology diseases. Whenever relevant, supporting computational studies will be also discussed.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UID/Multi/04349/2013, PTDC/QUI-OUT/32243/2017, PTDC/QUI-NUC/30147/2017, SFRH/BPD/97650/2013, SFRH/BD/135915/2018)
This publication has 223 references indexed in Scilit:
- Structural Basis of Wnt Recognition by FrizzledScience, 2012
- Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTPNuclear Medicine and Biology, 2012
- Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR)Bioorganic & Medicinal Chemistry, 2011
- Influence of Charge on Cell Permeability and Tumor Imaging of GPR30-Targeted 111In-Labeled Nonsteroidal Imaging AgentsACS Chemical Biology, 2010
- Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumorsAmino Acids, 2010
- Synthesis and Characterization of Iodinated Tetrahydroquinolines Targeting the G Protein-Coupled Estrogen Receptor GPR30Journal of Medicinal Chemistry, 2009
- In vivo effects of a GPR30 antagonistNature Chemical Biology, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Imaging in the era of molecular oncologyNature, 2008
- Linkage Effects on Binding Affinity and Activation of GPR30 and Estrogen Receptors ERα/β with Tridentate Pyridin-2-yl Hydrazine Tricarbonyl−Re/99mTc(I) ChelatesJournal of the American Chemical Society, 2006